|
Board of Directors
 Dr. Hans Black
Dr. Black received a Bachelor of Science
from Union College in New York, law
training in France and a Doctorate in
Medicine from McGill University. He is a
founder and CEO of Interinvest, a global
money management firm which manages
accounts for private and institutional clients
who are serviced through offices in Boston
and Montreal, and its affiliate offices in
Bermuda, London and Zurich. He has been
widely quoted, appearing in publications
such as Barron’s, The International Herald
Tribune, The Financial Times, Euromoney
and The Wall Street Transcript and appears
frequently as a special guest on The Nightly
Business Report. Dr. Black is a member of the board of
Abitibi-Consolidated Inc., Wi2Wi Inc., and
Les Aliments Soyummi Inc. He serves on
the Advisory Council of The Paul H. Nitze
School of Advanced International Studies of
Johns Hopkins University and the boards of
the Montreal Symphony Orchestra, la
Fondation Institut de Cardiologie de
Montréal, Fondation Jeunesses Musicales du Canada, l’Orchestre de chambre I Musici de Montréal, Canadian Vocal Art Institute, The National Arts Centre and the Washington National Opera.
 William Lambert
Mr. Lambert is a Special Partner with Birch Hill Equity Partners where he advises on sourcing, monitoring and creating value in its investee companies. Mr. Lambert previously held the position of Managing Director of TD Capital, the private equity arm of the Toronto-Dominion Bank. He has over 12 years experience in merchant banking and investing, and 10 years experience in consulting. Mr. Lambert received his undergraduate degree from Massachusetts Institute of Technology and his M.B.A. from York University. He serves on the boards of a number of private companies and one other public company, Marsulex Inc.
 Aziz Mekouar
Mr. Mekouar is currently the Ambassador of Morocco to the United States and participated in the negotiation of the Morocco/United States free trade agreement and the Millennium Challenge Account wherein the United States granted US$697 million for Moroccan development projects. He has previously served as the Ambassador of Morocco to several European countries and other countries throughout the world. He has also served as Chairman of the Council and member of the United Nations Food and Agriculture Organization, which exercises functions dealing with world food and agriculture and related matters including their impact on human health. Mr. Mekouar obtained his business degree from l’Ecole des Hautes Commerciales of Paris and frequently lectures on the economy and politics in universities and international conferences.
 Michael Sonnenreich
Mr. Sonnenreich is a graduate of Harvard University Law School, the University of Wisconsin and the University of Madrid. He is the Chairman and CEO of Kikaku America International and President and CEO of Glocal Communications Corp. Ltd. of London. He is Vice Chairman of the Board of PharMa International Corporation of Tokyo, a Director of Asset Advisory Services of Zurich, an Advisor of Johns Hopkins University School of Advanced International Studies and an Overseer of Tufts University Medical School. Mr. Sonnenreich has been a Board member and Trustee of numerous companies and universities including Scientific American Magazine, Penn Dixie Industries, ABD American Capital Market Funds, the Integra Fund, Medical Tribune International, Continental Steel Inc, Clark University, the Maret School and the Washington National Opera (President). He was President of the National Coordinating Council on Drug Education.
 Graham Strachan
Mr. Strachan has been involved in the Canadian
bio-technology industry for 25 years. He was one of the founders of Allelix
serving as president and CEO from 1986 until 1999 when Allelix was acquired by
a large US biotechnology company. Mr. Strachan is presently a principal of GLS
Business Development Inc. providing management and business development
services to biotechnology organizations. Mr. Strachan serves on the Board of
Directors of a number of public companies including IBEX Biotechnologies Inc.,
Lorus Therapeutics Inc., Millenium Biologix Inc., NIR Inc., and VIVUS Inc, as
well as several private companies. For his community services, Mr. Strachan was
the recipient of a Lifetime Achievement Award by the Toronto Biotechnology
Initiative in 2003. He is a Chemistry graduate from the University of Glasgow,
a registered Patent Agent and a Fellow Emeritus of the Intellectual Property
Institute of Canada.
 Dr. George Adams
CEO, Amorfix Life Sciences – See bio under Management
|
